Haleon (NYSE:HLN) Coverage Initiated at Berenberg Bank

Berenberg Bank started coverage on shares of Haleon (NYSE:HLN) in a report issued on Wednesday morning, Marketbeat.com reports. The firm issued a buy rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Argus reaffirmed a buy rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC started coverage on shares of Haleon in a research report on Wednesday, April 17th. They issued a buy rating for the company. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Haleon has a consensus rating of Moderate Buy.

Haleon Stock Performance

NYSE:HLN opened at $8.52 on Wednesday. The company has a market cap of $38.90 billion, a price-to-earnings ratio of 28.40, a price-to-earnings-growth ratio of 2.28 and a beta of 0.26. The company has a fifty day simple moving average of $8.34 and a two-hundred day simple moving average of $8.34. Haleon has a 52 week low of $7.70 and a 52 week high of $8.96. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53.

Haleon (NYSE:HLN) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.01. The business had revenue of $3.70 billion during the quarter, compared to analysts’ expectations of $3.71 billion. Haleon had a net margin of 9.68% and a return on equity of 13.17%. As a group, equities analysts anticipate that Haleon will post 0.46 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Haleon

Institutional investors and hedge funds have recently bought and sold shares of the stock. Hexagon Capital Partners LLC lifted its position in Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock valued at $35,000 after acquiring an additional 2,193 shares during the last quarter. Pinnacle Bancorp Inc. raised its holdings in shares of Haleon by 853.4% in the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock valued at $39,000 after buying an additional 4,267 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in shares of Haleon in the first quarter valued at about $43,000. Tower Research Capital LLC TRC raised its holdings in shares of Haleon by 146.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company’s stock valued at $44,000 after buying an additional 3,211 shares during the last quarter. Finally, SRS Capital Advisors Inc. raised its holdings in shares of Haleon by 456.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock valued at $45,000 after buying an additional 4,477 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.